GLENMARK
Invest Now
Start SIP in
GLENMARK
Performance
- Low
- ₹1,409
- High
- ₹1,439
- 52 Week Low
- ₹1,000
- 52 Week High
- ₹1,831
- Open Price₹1,433
- Previous Close₹1,431
- Volume344,400
Investment Returns
- Over 1 Month + 1.74%
- Over 3 Month + 8.78%
- Over 6 Month -4.28%
- Over 1 Year + 38%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -227.1
- PEG Ratio
- -2.9
- Market Cap Cr
- 39,931
- P/B Ratio
- 4.7
- Average True Range
- 42.95
- EPS
- 0
- Dividend Yield
- 0.2
- MACD Signal
- 1.72
- RSI
- 52.19
- MFI
- 67.07
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,415.00
-16.4
(-1.15%)

-
- Bearish Moving Average 14
-
- Bullish Moving Average 2
- 20 Day
- ₹1,423.13
- 50 Day
- ₹1,426.13
- 100 Day
- ₹1,446.05
- 200 Day
- ₹1,423.88
Resistance and Support
1429.43
- R3 1,464.17
- R2 1,451.93
- R1 1,441.67
- S1 1,419.17
- S2 1,406.93
- S3 1,396.67
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-23 | Audited Results & Final Dividend | |
2025-02-14 | Quarterly Results | |
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-24 | Audited Results & Final Dividend |
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,415 As on 23 May, 2025 | 13:14
The Market Cap of Glenmark Pharmaceuticals is ₹39931.4 Cr As on 23 May, 2025 | 13:14
The P/E ratio of Glenmark Pharmaceuticals is -227.1 As on 23 May, 2025 | 13:14
The PB ratio of Glenmark Pharmaceuticals is 4.7 As on 23 May, 2025 | 13:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.